1-14 of 14
Cyrus Khan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed-Duration Glofitamab Monotherapy Continues to Demonstrate Durable Responses in Patients with Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-up from a Pivotal Phase II Study

Michael J. Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Guillaume Cartron, Paolo Corradini, Nancy L. Bartlett, Gloria Iacoboni, Cyrus Khan, Mark S. Hertzberg, Lorenzo Falchi, Joshua Brody, Marek Trněný, Estefania Mulvihill, Aurelien Berthier, Alessia Bottos, James Relf, Fabiola Bene Tchaleu, Linda Lundberg, Martin Hutchings
Journal: Blood
Blood (2024) 144 (Supplement 1): 865.
https://doi.org/10.1182/blood-2024-194333
Published: 2024
Journal Articles

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study

Taylor R. Brooks, Emily C. Zabor, Yohana B. Bedelu, Nikita Dave, Daniel J. Landsburg, Adrienne N. Nedved, Yucai Wang, Catherine Reinert, Ajay Major, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Jordan Miller, Natalie Grover, Chelsea Peterson, Cyrus Khan, Sean Patrick Bliven, Mayur S. Narkhede, Carrie I Ho, Stephen D. Smith, Alyssa Gibson, Justin Kline, Suchitra Sundaram, Joshua Brody, Kelsey Baron, Boyu Hu, Daniel Trotier, Priyanka A. Pophali, XI Yang, Yasmin H. Karimi, Marshall McKenna, Yun Kyoung Tiger, Alex Niu, Francisco Hernandez-Ilizaliturri, Rodolfo Garza Morales, Javier Munoz, Fadzai Chinyengetere, Sandeep Dave, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Paolo F. Caimi, Brian T. Hill
Journal: Blood
Blood (2024) 144 (Supplement 1): 111.
https://doi.org/10.1182/blood-2024-199330
Published: 2024
Journal Articles

Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase II Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume

Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Lorenzo Falchi, Emmanuel Bachy, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua Brody, Sirpa Leppä, Pauline Baumlin, Estefania Mulvihill, James Relf, Yuying Xie, Derrick Kaufman, Linda Lundberg, Michael Dickinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 433.
https://doi.org/10.1182/blood-2023-173951
Published: 2023
Journal Articles

Dexamethasone is Associated with a Lower Incidence and Severity of Cytokine Release Syndrome Compared with Other Corticosteroid Regimens When Given as Premedication for Glofitamab Monotherapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Lorenzo Falchi, Carmelo Carlo-Stella, Franck Morschhauser, Michael Dickinson, Emmanuel Bachy, Guillaume Cartron, Cyrus Khan, Monica Tani, Joaquin Martinez-Lopez, Nancy L. Bartlett, Antonio Salar, Joshua Brody, Sirpa Leppä, Aurelien Berthier, Martine Kallemeijn, James Relf, Saibah Chohan, Linda Lundberg, Martin Hutchings
Journal: Blood
Blood (2023) 142 (Supplement 1): 3130.
https://doi.org/10.1182/blood-2023-173949
Published: 2023
Journal Articles

Is Breast Involvement in Marginal Zone Lymphoma Associated with Worse Outcomes? a Nationwide Analysis

Mohammad M Alhousani, Kiley Felton, Kathleen Faringer, Cyrus Khan, John Lister, Yazan Samhouri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6157.
https://doi.org/10.1182/blood-2023-188039
Published: 2023
Journal Articles

Relapse Is Uncommon in Patients with Large B-Cell Lymphoma Who Are in Complete Remission at the End of Fixed-Course Glofitamab Treatment

Martin Hutchings, Carmelo Carlo-Stella, Franck Morschhauser, Emmanuel Bachy, Paolo Corradini, Gloria Iacoboni, Cyrus Khan, Krish Patel, Mark Hertzberg, Lorenzo Falchi, Nancy L. Bartlett, Joshua Brody, Linda Lundberg, Yuying Xie, Estefania Mulvihill, Pauline Baumlin, James Relf, Emily Piccione, Kathryn Humphrey, Michael Dickinson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1062–1064.
https://doi.org/10.1182/blood-2022-157554
Published: 2022
Journal Articles

A Case of Primary Dural Lymphoma Treated with Bendamustine and Rituxan

Sushanth Sreenivasan, Shivani Shah, Risha Solanki, Pragnan Kancharla, John Lister, Cyrus Khan, Yazan Samhouri
Journal: Blood
Blood (2022) 140 (Supplement 1): 11995–11996.
https://doi.org/10.1182/blood-2022-168162
Published: 2022
Journal Articles

Treatment Outcomes for Follicular Lymphoma with Progression of Disease within 24 Months of Front-Line Therapy: A Systematic Review

Raheel S Siddiqui, Moazzam Shahzad, Saba Ahmed, Sara J Zaidi, Sara Shahid, Suneeba Chattha, Cyrus Khan, Faiz Anwer
Journal: Blood
Blood (2021) 138 (Supplement 1): 4521.
https://doi.org/10.1182/blood-2021-145502
Published: 2021
Journal Articles

Glofitamab Monotherapy Provides Durable Responses after Fixed-Length Dosing in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (pts)

Michael Dickinson, Carmelo Carlo-Stella, Franck Morschhauser, Krish Patel, Cyrus Khan, Nancy L. Bartlett, Gloria Iacoboni, Mark Hertzberg, Sirpa Leppä, Eric Van Den Neste, Monica Tani, Guillaume Cartron, Antonio Salar, David Perez-Callejo, Linda Lundberg, James Relf, Emma Clark, Kathryn Humphrey, Martin Hutchings
Journal: Blood
Blood (2021) 138 (Supplement 1): 2478.
https://doi.org/10.1182/blood-2021-146845
Published: 2021
Journal Articles

Predictors and Long Term Outcomes for DLBCL Patients Undergoing Surgery Prior to Systemic Therapy

Thejus Jayakrishnan, MBBS, Yazan Samhouri, MD, Veli Bakalov, MD, Zena Chahine, MD, Rodney E Wegner, MD, Cyrus Khan, MD, Salman Fazal, MD, John Lister, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-137827
Published: 2020
Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

Anas Younes, MD, John M Burke, MD, Bruce D. Cheson, MD, Catherine Diefenbach, MD, Silvia Ferrari, MD, Uwe H Hahn, MD, Eliza A Hawkes, Cyrus Khan, MD, Izidore S. Lossos, MD, Gerardo Musuraca, MD PhD, Monica Tani, Umberto Vitolo, Sam Lung Sang Yuen, MBBS,FRCPA,FRACP, Aparna Raval, PhD, Mahesh R. Shivhare, PhD, Tina G Nielsen, MD PhD, Gila Sellam, PhD, Jeff P. Sharman, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2874.
https://doi.org/10.1182/blood-2019-123368
Published: 2019
Journal Articles

Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Primary Analysis of a Phase I/II Study

Anas Younes, MD, John M Burke, Bruce Cheson, MD, Catherine Diefenbach, MD, Silvia Ferrari, Uwe Hahn, Eliza Hawkes, Cyrus Khan, Izidore S. Lossos, MD, Gerardo Musuraka, Monica Tani, Umberto Vitolo, Sam Yuen, Mikkel Z Oestergaard, Surya Chitra, Michael Wenger, Tina Nielsen, Gila Sellam, Jeff Sharman, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2969.
https://doi.org/10.1182/blood-2018-99-116678
Published: 2018
Journal Articles

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Parikshit Padhi, MD, Abhishek Chilkulwar, MD, Cyrus Khan, MD, Monank Patel, PharmD, BCOP, John Lister, MD, Xiaoqin Tang, PhD Director of Biostatistics
Journal: Blood
Blood (2016) 128 (22): 5410.
https://doi.org/10.1182/blood.V128.22.5410.5410
Published: 2016
Journal Articles

Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL

Abhishek Chilkulwar, MD, Salman Fazal, MD, Jocelyn T. De Yao, MD, Parik Padhi, MD, Cyrus Khan, MD, John Lister, MD
Journal: Blood
Blood (2015) 126 (23): 4907.
https://doi.org/10.1182/blood.V126.23.4907.4907
Published: 2015